Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Professional, scientific, and technical services entities : Impel neuropharma inc. save search
Impel Pharmaceuticals Announces Exploration of Strategic Alternatives
Published: 2023-10-05 (Crawled : 12:00) - globenewswire.com
IMPL 4 | $0.2411 -77.19% 860K
|
Professional, Scientific, and T...
|
| O: 4.34%
H: 2.24%
C: -3.25%
MC | $51.65 1.33% 0.0% 590K
|
Finance
|
| O: 0.16%
H: 2.26%
C: 1.64%
pharmaceuticals
Impel Pharmaceuticals to Present New Real-World Data for Trudhesa® at the 65th Annual Scientific Meeting of the American Headache Society
Published: 2023-06-15 (Crawled : 12:00) - globenewswire.com
IMPL 4 | $0.2411 -77.19% 860K
|
Professional, Scientific, and T...
|
| O: 2.63%
H: 0.51%
C: -0.26%
trudhesa pharmaceuticals meeting
Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update
Published: 2023-05-12 (Crawled : 12:00) - globenewswire.com
IMPL 4 | $0.2411 -77.19% 860K
|
Professional, Scientific, and T...
|
| O: -12.28%
H: 1.5%
C: -24.0%
business update pharmaceuticals financial results
Impel Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial Officer
Published: 2023-05-10 (Crawled : 12:00) - globenewswire.com
IMPL 4 | $0.2411 -77.19% 860K
|
Professional, Scientific, and T...
|
| O: -3.92%
H: 2.04%
C: -0.82%
AMRN | News | $0.88 0.94% 0.93% 1M
|
Health Technology
|
| O: 0.75%
H: 0.0%
C: -5.22%
pharmaceuticals financial
Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023
Published: 2023-05-05 (Crawled : 12:00) - globenewswire.com
IMPL 4 | $0.2411 -77.19% 860K
|
Professional, Scientific, and T...
|
| O: 12.55%
H: 3.46%
C: 0.0%
report pharmaceuticals financial results
Impel Pharmaceuticals Presents New Data at AAN 2023 Suggesting Trudhesa® Nasal Spray is Safe to Use When Co-Administered With Commonly Prescribed Migraine Medications
Published: 2023-04-26 (Crawled : 13:20) - biospace.com/
IMPL 4 | $0.2411 -77.19% 860K
|
Professional, Scientific, and T...
|
| O: -4.28%
H: 16.97%
C: 5.45%
trudhesa pharmaceuticals safe spray migraine
Cellarity Strengthens Executive Leadership Team
Published: 2023-04-11 (Crawled : 14:00) - biospace.com/
MNK | $0.3402 -0.06% 540K
|
n/a
|
| O: 0.21%
H: 16.84%
C: 11.73%
OMGA | $2.4 -0.83% -0.83% 400K
|
|
| O: -0.38%
H: 2.44%
C: 1.67%
IMPL 4 | $0.2411 -77.19% 860K
|
Professional, Scientific, and T...
|
| O: 0.75%
H: 1.87%
C: 0.75%
SANA | $7.605 -1.62% -1.64% 3.4M
|
|
| O: 0.0%
H: 11.28%
C: 11.28%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.06%
H: 0.52%
C: -0.09%
MCRB | $0.5671 -2.93% -3.02% 3.7M
|
Health Technology
|
| O: 1.59%
H: 4.17%
C: 1.56%
SELB 4 | $0.8812 -8.0% 2.12% 0
|
Health Technology
|
| O: 0.0%
H: 2.33%
C: 1.55%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: -4.82%
H: 2.85%
C: 1.85%
FHTX | $5.335 -3.53% -3.66% 120K
|
Health Technology
|
| O: 0.43%
H: 7.91%
C: 6.21%
EVLO | $0.3165 -87.39% 710K
|
Health Technology
|
| O: 38.25%
H: 0.0%
C: -38.93%
DNLI | $15.98 -3.74% -3.88% 1.5M
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: -0.75%
Impel Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Published: 2023-03-24 (Crawled : 12:20) - globenewswire.com
IMPL 4 | $0.2411 -77.19% 860K
|
Professional, Scientific, and T...
|
| O: 5.34%
H: 10.86%
C: -1.45%
business year update pharmaceuticals financial results
Impel Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on Friday, March 24, 2023
Published: 2023-03-17 (Crawled : 12:20) - globenewswire.com
IMPL 4 | $0.2411 -77.19% 860K
|
Professional, Scientific, and T...
|
| O: 5.15%
H: 17.65%
C: 2.94%
report year pharmaceuticals financial results
Impel Pharmaceuticals to Participate in Upcoming Investor Conferences in March
Published: 2023-03-03 (Crawled : 21:00) - globenewswire.com
IMPL 4 | $0.2411 -77.19% 860K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
pharmaceuticals
Impel Pharmaceuticals Announces Strategic Reprioritization, Continues Focus on Maximizing Trudhesa® Commercial Opportunity
Published: 2023-02-22 (Crawled : 23:00) - globenewswire.com
IMPL 4 | $0.2411 -77.19% 860K
|
Professional, Scientific, and T...
|
| O: -2.81%
H: 0.44%
C: -27.11%
trudhesa pharmaceuticals commercial
Impel Pharmaceuticals Announces Strategic Repriortization, Continues Focus on Maximizing Trudhesa® Commercial Opportunity
Published: 2023-02-22 (Crawled : 22:00) - globenewswire.com
IMPL 4 | $0.2411 -77.19% 860K
|
Professional, Scientific, and T...
|
| O: -2.81%
H: 0.44%
C: -27.11%
trudhesa pharmaceuticals commercial
Impel Pharmaceuticals Announces Third Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-11-14 (Crawled : 13:00) - globenewswire.com
IMPL 4 | $0.2411 -77.19% 860K
|
Professional, Scientific, and T...
|
| O: 0.79%
H: 3.65%
C: -12.5%
pharmaceuticals financial update results
Impel Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-08-15 (Crawled : 12:20) - globenewswire.com
IMPL 4 | $0.2411 -77.19% 860K
|
Professional, Scientific, and T...
|
| O: -8.51%
H: 6.53%
C: -1.51%
update results
Impel Pharmaceuticals to Report Second Quarter 2022 Financial Results on Monday, August 15, 2022
Published: 2022-08-08 (Crawled : 13:20) - biospace.com/
IMPL 4 | $0.2411 -77.19% 860K
|
Professional, Scientific, and T...
|
| O: -1.16%
H: 4.95%
C: 2.71%
report results
Impel Pharmaceuticals to Participate in 2022 Wedbush PacGrow Healthcare Conference
Published: 2022-08-02 (Crawled : 14:00) - biospace.com/
IMPL 4 | $0.2411 -77.19% 860K
|
Professional, Scientific, and T...
|
| O: -3.1%
H: 4.1%
C: 2.56%
conference
Impel Pharmaceuticals Announces First Patient Dosed in Phase 2a Study Evaluating INP105 to Treat Acute Agitation in Adolescents With Autism Spectrum Disorder (ASD)
Published: 2022-07-19 (Crawled : 16:00) - biospace.com/
IMPL 4 | $0.2411 -77.19% 860K
|
Professional, Scientific, and T...
|
| O: 3.46%
H: 1.55%
C: -0.24%
inp105 study phase 2b lsd
Impel Pharmaceuticals to Present Trudhesa® Data at the 64th Annual Meeting of the American Headache Society
Published: 2022-06-09 (Crawled : 12:20) - globenewswire.com
IMPL 4 | $0.2411 -77.19% 860K
|
Professional, Scientific, and T...
|
| O: -6.87%
H: 4.3%
C: -0.7%
trudhesa
Impel Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-05-16 (Crawled : 19:00) - biospace.com/
IMPL 4 | $0.2411 -77.19% 860K
|
Professional, Scientific, and T...
|
| O: 0.77%
H: 6.3%
C: 4.15%
results
Impel Pharmaceuticals to Report First Quarter 2022 Financial Results on Monday, May 16, 2022
Published: 2022-05-09 (Crawled : 13:20) - biospace.com/
IMPL 4 | $0.2411 -77.19% 860K
|
Professional, Scientific, and T...
|
| O: -2.96%
H: 2.9%
C: -9.45%
report results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.